PHC3, a component of the hPRC-H complex, associates with E2F6 during G 0 and is lost in osteosarcoma tumors

A. M. Deshpande, J. D. Akunowicz, X. T. Reveles, B. B. Patel, E. A. Saria, R. G. Gorlick, S. L. Naylor, R. J. Leach, M. F. Hansen

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Polyhomeotic-like 3 (PHC3) is a ubiquitously expressed member of the polycomb gene family and part of the human polycomb complex hPRC-H. We found that in normal cells PHC3 associated with both hPRC-H complex components and with the transcription factor E2F6. In differentiating and confluent cells, PHC3 and E2F6 showed nuclear colocalization in a punctate pattern that resembled the binding of polycomb bodies to heterochromatin. This punctate pattern was not seen in proliferating cells suggesting that PHC3 may be part of an E2F6-polycomb complex that has been shown to occupy and silence target promoters in G 0. Previous loss of heterozygosity (LoH) analyses had shown that the region containing PHC3 underwent frequent LoH in primary human osteosarcoma tumors. When we examined normal bone and human osteosarcoma tumors, we found loss of PHC3 expression in 36 of 56 osteosarcoma tumors. Sequence analysis revealed that PHC3 was mutated in nine of 15 primary osteosarcoma tumors. These findings suggest that loss of PHC3 may favor tumorigenesis by potentially disrupting the ability of cells to remain in G0.

Original languageEnglish (US)
Pages (from-to)1714-1722
Number of pages9
JournalOncogene
Volume26
Issue number12
DOIs
StatePublished - Mar 15 2007

Fingerprint

Osteosarcoma
Loss of Heterozygosity
E2F6 Transcription Factor
Heterochromatin
Sequence Analysis
Carcinogenesis
Bone and Bones
Genes

Keywords

  • Cell cycle regulation
  • Osteosarcoma
  • Polycomb gene
  • Polyhomeotic-like
  • Tumor suppressor gene

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Deshpande, A. M., Akunowicz, J. D., Reveles, X. T., Patel, B. B., Saria, E. A., Gorlick, R. G., ... Hansen, M. F. (2007). PHC3, a component of the hPRC-H complex, associates with E2F6 during G 0 and is lost in osteosarcoma tumors. Oncogene, 26(12), 1714-1722. https://doi.org/10.1038/sj.onc.1209988

PHC3, a component of the hPRC-H complex, associates with E2F6 during G 0 and is lost in osteosarcoma tumors. / Deshpande, A. M.; Akunowicz, J. D.; Reveles, X. T.; Patel, B. B.; Saria, E. A.; Gorlick, R. G.; Naylor, S. L.; Leach, R. J.; Hansen, M. F.

In: Oncogene, Vol. 26, No. 12, 15.03.2007, p. 1714-1722.

Research output: Contribution to journalArticle

Deshpande, AM, Akunowicz, JD, Reveles, XT, Patel, BB, Saria, EA, Gorlick, RG, Naylor, SL, Leach, RJ & Hansen, MF 2007, 'PHC3, a component of the hPRC-H complex, associates with E2F6 during G 0 and is lost in osteosarcoma tumors', Oncogene, vol. 26, no. 12, pp. 1714-1722. https://doi.org/10.1038/sj.onc.1209988
Deshpande AM, Akunowicz JD, Reveles XT, Patel BB, Saria EA, Gorlick RG et al. PHC3, a component of the hPRC-H complex, associates with E2F6 during G 0 and is lost in osteosarcoma tumors. Oncogene. 2007 Mar 15;26(12):1714-1722. https://doi.org/10.1038/sj.onc.1209988
Deshpande, A. M. ; Akunowicz, J. D. ; Reveles, X. T. ; Patel, B. B. ; Saria, E. A. ; Gorlick, R. G. ; Naylor, S. L. ; Leach, R. J. ; Hansen, M. F. / PHC3, a component of the hPRC-H complex, associates with E2F6 during G 0 and is lost in osteosarcoma tumors. In: Oncogene. 2007 ; Vol. 26, No. 12. pp. 1714-1722.
@article{cb480dd48a1a4fdf8d5c34f0ebaaede4,
title = "PHC3, a component of the hPRC-H complex, associates with E2F6 during G 0 and is lost in osteosarcoma tumors",
abstract = "Polyhomeotic-like 3 (PHC3) is a ubiquitously expressed member of the polycomb gene family and part of the human polycomb complex hPRC-H. We found that in normal cells PHC3 associated with both hPRC-H complex components and with the transcription factor E2F6. In differentiating and confluent cells, PHC3 and E2F6 showed nuclear colocalization in a punctate pattern that resembled the binding of polycomb bodies to heterochromatin. This punctate pattern was not seen in proliferating cells suggesting that PHC3 may be part of an E2F6-polycomb complex that has been shown to occupy and silence target promoters in G 0. Previous loss of heterozygosity (LoH) analyses had shown that the region containing PHC3 underwent frequent LoH in primary human osteosarcoma tumors. When we examined normal bone and human osteosarcoma tumors, we found loss of PHC3 expression in 36 of 56 osteosarcoma tumors. Sequence analysis revealed that PHC3 was mutated in nine of 15 primary osteosarcoma tumors. These findings suggest that loss of PHC3 may favor tumorigenesis by potentially disrupting the ability of cells to remain in G0.",
keywords = "Cell cycle regulation, Osteosarcoma, Polycomb gene, Polyhomeotic-like, Tumor suppressor gene",
author = "Deshpande, {A. M.} and Akunowicz, {J. D.} and Reveles, {X. T.} and Patel, {B. B.} and Saria, {E. A.} and Gorlick, {R. G.} and Naylor, {S. L.} and Leach, {R. J.} and Hansen, {M. F.}",
year = "2007",
month = "3",
day = "15",
doi = "10.1038/sj.onc.1209988",
language = "English (US)",
volume = "26",
pages = "1714--1722",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - PHC3, a component of the hPRC-H complex, associates with E2F6 during G 0 and is lost in osteosarcoma tumors

AU - Deshpande, A. M.

AU - Akunowicz, J. D.

AU - Reveles, X. T.

AU - Patel, B. B.

AU - Saria, E. A.

AU - Gorlick, R. G.

AU - Naylor, S. L.

AU - Leach, R. J.

AU - Hansen, M. F.

PY - 2007/3/15

Y1 - 2007/3/15

N2 - Polyhomeotic-like 3 (PHC3) is a ubiquitously expressed member of the polycomb gene family and part of the human polycomb complex hPRC-H. We found that in normal cells PHC3 associated with both hPRC-H complex components and with the transcription factor E2F6. In differentiating and confluent cells, PHC3 and E2F6 showed nuclear colocalization in a punctate pattern that resembled the binding of polycomb bodies to heterochromatin. This punctate pattern was not seen in proliferating cells suggesting that PHC3 may be part of an E2F6-polycomb complex that has been shown to occupy and silence target promoters in G 0. Previous loss of heterozygosity (LoH) analyses had shown that the region containing PHC3 underwent frequent LoH in primary human osteosarcoma tumors. When we examined normal bone and human osteosarcoma tumors, we found loss of PHC3 expression in 36 of 56 osteosarcoma tumors. Sequence analysis revealed that PHC3 was mutated in nine of 15 primary osteosarcoma tumors. These findings suggest that loss of PHC3 may favor tumorigenesis by potentially disrupting the ability of cells to remain in G0.

AB - Polyhomeotic-like 3 (PHC3) is a ubiquitously expressed member of the polycomb gene family and part of the human polycomb complex hPRC-H. We found that in normal cells PHC3 associated with both hPRC-H complex components and with the transcription factor E2F6. In differentiating and confluent cells, PHC3 and E2F6 showed nuclear colocalization in a punctate pattern that resembled the binding of polycomb bodies to heterochromatin. This punctate pattern was not seen in proliferating cells suggesting that PHC3 may be part of an E2F6-polycomb complex that has been shown to occupy and silence target promoters in G 0. Previous loss of heterozygosity (LoH) analyses had shown that the region containing PHC3 underwent frequent LoH in primary human osteosarcoma tumors. When we examined normal bone and human osteosarcoma tumors, we found loss of PHC3 expression in 36 of 56 osteosarcoma tumors. Sequence analysis revealed that PHC3 was mutated in nine of 15 primary osteosarcoma tumors. These findings suggest that loss of PHC3 may favor tumorigenesis by potentially disrupting the ability of cells to remain in G0.

KW - Cell cycle regulation

KW - Osteosarcoma

KW - Polycomb gene

KW - Polyhomeotic-like

KW - Tumor suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=33947253984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947253984&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1209988

DO - 10.1038/sj.onc.1209988

M3 - Article

C2 - 17001316

AN - SCOPUS:33947253984

VL - 26

SP - 1714

EP - 1722

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 12

ER -